You just read:

LSK BioPharma and Jiangsu Hengrui Medicine Announce FDA Clearance to Initiate a Phase 3 Clinical Trial in Advanced Hepatocellular Carcinoma (HCC)

News provided by

LSK BioPharma

Apr 08, 2019, 20:00 ET